TABLE 3.
Dose volume objectives used for the HIPO plans.
| Contour | Min (% PD) | Weight | Max (% PD) | Weight | Priority |
|---|---|---|---|---|---|
| HR CTV | 140 | 100 | 500 | 0.1 | 5 |
| IR CTV | 100 | 10 | 200 | 50 | 6 |
| Bladder | 80 | 70 | 1 | ||
| Rectum | 70 | 50 | 2 | ||
| Sigmoid | 70 | 50 | 3 | ||
| Bowel | 70 | 50 | 4 | ||
| Normal tissue | 100 | 1 | ‐ |
Dose volume objectives used for the HIPO plans.
| Contour | Min (% PD) | Weight | Max (% PD) | Weight | Priority |
|---|---|---|---|---|---|
| HR CTV | 140 | 100 | 500 | 0.1 | 5 |
| IR CTV | 100 | 10 | 200 | 50 | 6 |
| Bladder | 80 | 70 | 1 | ||
| Rectum | 70 | 50 | 2 | ||
| Sigmoid | 70 | 50 | 3 | ||
| Bowel | 70 | 50 | 4 | ||
| Normal tissue | 100 | 1 | ‐ |